AT
RDY icon

Arlington Trust’s Dr. Reddy's Laboratories RDY Stock Holding History

Arlington Trust’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-340
Closed -$4.75K – 591
2025
Q3 		$4.75K Hold
340
– – ﹤0.01% 525
2025
Q2 		$5.11K Hold
340
– – ﹤0.01% 529
2025
Q1 		$4.49K Hold
340
– – ﹤0.01% 564
2024
Q4 		$5.37K Hold
340
– – ﹤0.01% 504
2024
Q3 		$5.4K Hold
340
– – ﹤0.01% 487
2024
Q2 		$5.18K Hold
340
– – ﹤0.01% 484
2024
Q1 		$4.99K Hold
340
– – ﹤0.01% 433
2023
Q4 		$4.73K Buy
+340
New +$4.55K ﹤0.01% 482

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Arlington Trust's RDY Position: Q4 2025 in Review

Arlington Trust sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 340 shares — an estimated $4.75K sold.

Arlington Trust first reported a position in RDY in Q4 2023 and held it in 8 quarters. The position peaked at $5.4K in Q3 2024. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Arlington Trust reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Arlington Trust sold 340 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $4.75K.
  • Arlington Trust first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 8 quarters.
  • Arlington Trust's Dr. Reddy's Laboratories position peaked at $5.4K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Arlington Trust's 13F filing for Q4 2025, filed 30 Jan 2026.